EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
3.4.22.29 | 755620 |
A comprehensive computational mutation structure-function approach for determining potential drug target sites in poliovirus 2A protease |
Trop. J. Pharm. Res. |
16 |
2831-2841 |
2017 |
Human poliovirus 1 |
- |
3.4.22.29 | 753178 |
Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes |
Cell Death Differ. |
23 |
828-840 |
2016 |
Coxsackievirus B3 |
26586572 |
3.4.22.29 | 753654 |
Cleavage of Grb2-associated binding protein 2 by viral proteinase 2A during coxsackievirus infection |
Front. Cell. Infect. Microbiol. |
7 |
85 |
2017 |
Coxsackievirus B3 |
28361043 |
3.4.22.29 | 755211 |
Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication |
PLoS Pathog. |
13 |
e1006744 |
2017 |
Coxsackievirus B3 |
29220410 |
3.4.22.29 | 755655 |
Coxsackievirus B3 responds to polyamine depletion via enhancement of 2A and 3C protease activity |
Viruses |
11 |
403 |
2019 |
Coxsackievirus B3 |
31052199 |
3.4.22.29 | 755655 |
Coxsackievirus B3 responds to polyamine depletion via enhancement of 2A and 3C protease activity |
Viruses |
11 |
403 |
2019 |
Coxsackievirus B3 Nancy |
31052199 |
3.4.22.29 | 754557 |
Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I Interferon |
J. Virol. |
93 |
e00222-19 |
2019 |
Coxsackievirus B3 |
30867299 |
3.4.22.29 | 754557 |
Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I Interferon |
J. Virol. |
93 |
e00222-19 |
2019 |
Enterovirus A71 |
30867299 |
3.4.22.29 | 754557 |
Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I Interferon |
J. Virol. |
93 |
e00222-19 |
2019 |
Enterovirus D68 |
30867299 |
3.4.22.29 | 754557 |
Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I Interferon |
J. Virol. |
93 |
e00222-19 |
2019 |
Coxsackievirus A21 |
30867299 |